Skip to main content
§ 01 · Metabolic Health · Kollam

Medical metabolic health in Kollam,
physician-led, GLP-1 era, Indian BMI thresholds.

Physician-led metabolic-health programme using lifestyle therapy as the foundation and GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) where clinically indicated for BMI ≥27 with co-morbidity or BMI ≥30. Indian BMI thresholds applied per ICMR: Overweight ≥23, Obese ≥25 — substantially lower than WHO defaults. Pre-treatment labs (fasting glucose, HbA1c, lipid panel, TSH, LFT, RFT), monthly follow-up, structured nutrition and resistance-exercise plan in parallel.

4.8★ 1,450 reviews
MD DVL Board-certified
US-FDA Approved lasers
ICMR Indian BMI 2009 thresholds
Kavanad on NH-66 · 5 min from Kollam Junction · Near RP Mall & Chinnakada
§ 04 · Why Indian Metabolic Health Is Different

Indian BMI thresholds are 23 / 25, not 25 / 30 — using WHO numbers misses the at-risk Indian patient by years.

The ICMR 2009 expert consensus on Indian BMI thresholds set Overweight at ≥23 and Obese at ≥25 — substantially lower than WHO defaults of 25 / 30 — based on Indian-cohort data showing cardio-metabolic risk equivalent to Europeans at lower BMI. Using WHO thresholds in Indian practice misses the early-intervention window by a decade. Our Kollam programme uses Indian thresholds throughout, adds waist circumference (Indian male >90 cm, female >80 cm) as an equally weighted risk marker, and screens for the metabolic-syndrome cluster (HTN, dyslipidaemia, fasting glucose) at every visit. GLP-1 receptor agonists are prescribed only on label for BMI ≥27 with co-morbidity or BMI ≥30, with monthly follow-up.

  • 23 / 25Indian BMI thresholds per ICMR 2009 — overweight ≥23, obese ≥25 (not WHO 25/30)
  • >90 / 80 cmwaist-circumference cut-off for Indian male / female metabolic risk
  • GLP-1semaglutide / liraglutide / tirzepatide on-label for BMI ≥27 + co-morbidity or BMI ≥30
ICMR Indian BMI Expert Consensus 2009 · Snehalatha C Diabetes Care 2003 Indian waist cut-offs
INDIAN BMI THRESHOLDS
23 BMI
Indian overweight threshold (ICMR 2009)
0%
18.5 23 25 100
§ 05 · Clinical Summary

The published protocol, in plain English.

DermaVue Kollam SuperHuman Programme provides dermatologist-supervised metabolic health and weight management combining GLP-1 receptor agonist therapy (where clinically indicated and screened), Kerala-adapted nutrition plans and longitudinal cardiometabolic monitoring. A 2025 New England Journal of Medicine study confirmed tirzepatide produces 16.5 percent body weight reduction at one year versus 14.1 percent for semaglutide, validated in real-world Indian cohorts through the SHAPE study (2026). The programme applies Indian-specific BMI thresholds (overweight 23, obese 25) per ICMR guidance rather than WHO Western thresholds. DermaVue is a dermatologist-owned network rated 4.9 stars in Kollam across 370+ patient reviews and serves patients from Chinnakada, Kadappakkada, Paravur, Kottarakkara and Punalur.

§ 08 · What's in the room

Eight modalities, sequenced per patient.

01

Dermatologist Evaluation + Metabolic Screening

HbA1c, fasting insulin, lipid panel, liver enzymes, thyroid panel, vitamin D

02

GLP-1 Receptor Agonist Therapy

semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro) when clinically indicated and contraindications screened

03

BIS Body Composition Tracking

bioimpedance spectroscopy to monitor muscle preservation alongside fat reduction

04

Kerala-Adapted Nutrition

registered-dietitian plans that retain kanji, appam, fish curry and traditional meals with modified portions

05

PCOS-Related Metabolic Programme

insulin sensitivity focus for women with PCOS and weight gain

06

Type 2 Diabetes + Weight Co-Management

combined glycaemic and weight optimisation with hypoglycaemia monitoring

07

Resistance Training Protocol

muscle-preserving exercise guidance with minimum 1.2 g protein per kg body weight per day

08

Longitudinal Follow-Up

monthly dermatologist review, dose titration, side-effect management and habit reinforcement

09

Structured Taper Planning

gradual GLP-1 dose reduction once metabolic targets and sustainable habits are established

10

Cardiometabolic Risk Reduction

blood pressure, lipid and HbA1c tracking aligned with longevity outcomes

§ 10 · Your dermatologists

Two physicians own every consultation note.

Dr Jayalekshmi J and Dr Arunima A both hold the MD DVL postgraduate qualification and own every file together. Continuity of care is the default, not a tagline.

  1. Dr. Jayalekshmi J, MD DVL, Consultant Dermatologist at DermaVue Kollam
    01

    Dr. Jayalekshmi J, MD DVL

    Consultant Dermatologist

    Dermatology, Cosmetology, Medical Dermatology

    • IADVL
    • ACSI
    • IMA
  2. Dr. Arunima A, MD DVL, Dermatologist & Dermatosurgeon at DermaVue Kollam
    02

    Dr. Arunima A, MD DVL

    Dermatologist & Dermatosurgeon

    Dermatology, Dermatosurgery, Lasers & Aesthetic Procedures

    • IADVL
    • ACSI

Direct line to the team WhatsApp +91 80868 60465 →

§ 11 · Frequently asked

The questions every Kollam metabolic-health patient asks. Honestly answered.

How much does the medical weight management programme cost in Kollam?

Initial consultation is Rs.300. Programme tiers and GLP-1 medication options are discussed transparently after metabolic screening. Brand semaglutide starts around Rs.5,660 per month at starter dose and varies with dose and brand. Indian generic semaglutide became available after the March 2026 patent expiry and is expected to reduce costs. Your dermatologist outlines all options.

Is GLP-1 therapy safe for long-term metabolic health?

GLP-1 receptor agonists have extensive safety data from large clinical trials. Side effects are primarily gastrointestinal (nausea, reduced appetite) and typically mild with gradual dose titration. Your dermatologist screens for contraindications including medullary thyroid cancer history, MEN-2, pancreatitis and gallbladder disease before prescribing, then monitors quarterly.

How quickly will I see metabolic improvements?

Most patients notice reduced appetite within the first week and improved fasting glucose within 4-6 weeks. Visceral fat (around the organs) often reduces faster than subcutaneous fat, so cardiometabolic risk markers can improve before the scale reflects the full change. Sustained body weight reduction continues over 4-12 months under dermatologist supervision.

Is tirzepatide better than semaglutide?

A 2025 NEJM study showed tirzepatide (Mounjaro) achieves around 16.5 percent body weight reduction at one year versus 14.1 percent for semaglutide (Ozempic). However, the best choice depends on your individual metabolic profile, side-effect tolerance, contraindications and budget. Your dermatologist recommends based on your specific situation, not on weight loss numbers alone.

Do I need GLP-1 injections forever?

No. Most patients use GLP-1 medications for 12-18 months while building sustainable nutrition and activity habits. The programme includes a structured taper plan once metabolic targets are reached. Some patients with type 2 diabetes may continue at a low maintenance dose for longer-term glycaemic and cardiometabolic benefit, under dermatologist review.

What diet do you recommend alongside GLP-1 therapy?

Our registered dietitian designs Kerala-adapted plans that work within your existing food preferences. White rice portions reduce, protein from fish and legumes increases, and tapioca frequency decreases. Kanji, appam and Kollam-style fish curry can be modified rather than eliminated. Minimum 1.2 g protein per kg body weight per day to preserve muscle mass.

Is the programme suitable for women with PCOS?

GLP-1 medications can be particularly helpful for PCOS-related weight gain because they improve insulin sensitivity, which is a core metabolic driver of PCOS. Improved insulin function often results in better hormone regulation, more regular cycles and reduced androgen-related symptoms alongside weight management. Our dermatologists in Kollam also address PCOS-related skin concerns such as acne and hirsutism.

Can exercise alone produce significant visceral fat reduction?

Exercise preserves muscle and improves metabolic health, but research consistently shows it produces modest body fat reduction when used alone (typically 2-3 percent). For significant visceral fat reduction and sustained metabolic improvement, structured nutrition and, where indicated, medication produce substantially better outcomes than exercise in isolation.

Can people with type 2 diabetes use GLP-1 for metabolic health?

Yes. Type 2 diabetes is a primary indication for GLP-1 medications. Semaglutide and tirzepatide improve both weight and blood sugar control simultaneously and have demonstrated cardiometabolic benefits. Patients already on diabetes medication need monitoring for hypoglycaemia, so your dermatologist adjusts all medications together.

What are the absolute contraindications to GLP-1 therapy?

Pregnancy and lactation, personal or family history of medullary thyroid carcinoma, MEN-2 syndrome, history of pancreatitis, type 1 diabetes, active gallbladder disease, severe gastroparesis and known hypersensitivity to semaglutide or tirzepatide. Patients with diabetic retinopathy need careful HbA1c reduction planning. Dermatologist screening at first consultation rules these out.

What is the SuperHuman Programme at DermaVue Kollam?

A dermatologist-supervised metabolic health programme combining four pillars: dermatologist evaluation with metabolic screening, GLP-1 receptor agonist medication where indicated, Kerala-adapted nutrition guidance, and muscle-preserving activity protocols with longitudinal cardiometabolic monitoring. The programme runs 12-18 months with regular dermatologist check-ins and body composition tracking, and is framed around long-term metabolic health and longevity rather than cosmetic weight loss.

How do I book a metabolic health consultation in Kollam?

WhatsApp DermaVue Kollam at +91 8086860465 or call directly. The clinic is at UMK Arcade, Vellayittambalam, Kavanad. Patients often combine the metabolic health programme with skin rejuvenation treatments such as Botox in Kollam. Initial consultation includes comprehensive assessment and personalised planning. Consultation fee: Rs.300.

§ 13 · Find us

5 min from Kollam Junction. Near RP Mall & Chinnakada.

Address
UMK Arcade, Vellayittambalam, Kavanad PO, Kollam, Kerala 691003
Hours
Mon–Sat 10 AM–7 PM, Sun Closed
KollamKavanadChinnakadaKarunagappallyParavurKundaraPunalurAnchal
§ 15 · Start today

Book the Indian-BMI + waist + labs + lifestyle review visit.
Pharmacotherapy is added where indicated, never as a stand-alone fix.

₹300 consultation · same-day slots available · Kavanad clinic open Mon–Sat 10 AM – 7 PM, Sun closed.

WhatsApp us instead
Call